BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND PHOX2B, 8929 AND Treatment
40 results:

  • 1. IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression.
    Hagemann S; Misiak D; Bell JL; Fuchs T; Lederer MI; Bley N; Hämmerle M; Ghazy E; Sippl W; Schulte JH; Hüttelmaier S
    Mol Cancer; 2023 May; 22(1):88. PubMed ID: 37246217
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Combined analysis of phox2b at two time points and its value for further risk stratification in high-risk neuroblastoma.
    Yue Z; Gao C; Xing T; Zhao W; Duan C; Wang X; Jin M; Su Y
    Pediatr Blood Cancer; 2023 May; 70(5):e30261. PubMed ID: 36815592
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Different tumorigenicity and distinct metastasis and gene signature between orthotopic and subcutaneous neuroblastoma xenografted mice.
    Han R; Zhao W; Gu X; Gao X; Yang YG; Zhang X
    Aging (Albany NY); 2022 Feb; 14(4):1932-1940. PubMed ID: 35197367
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ganglion cell maturation in peripheral neuroblastic tumours of children.
    Sarnat HB; Yu W
    Clin Neuropathol; 2022; 41(3):101-113. PubMed ID: 35142286
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma.
    Holliday H; Yang J; Dodson E; Nikolic I; Kamili A; Wheatley M; Deng N; Alexandrou S; Davis TP; Kavallaris M; Caldon CE; McCarroll J; De Preter K; Mestdagh P; Marshall GM; Simpson KJ; Fletcher J; Swarbrick A
    Mol Ther; 2022 Mar; 30(3):1119-1134. PubMed ID: 34998954
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Opsoclonus-Myoclonus-Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best treatment Option?
    Gizhlaryan M; Aghabekyan T; Arakelyan T; Petrosyan M; Iskanyan S; Tamamyan G; Sargsyan L; Papyan R
    Oncology (Williston Park); 2021 Oct; 35(10):665-667. PubMed ID: 34677924
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.
    von Hoff K; Haberler C; Schmitt-Hoffner F; Schepke E; de Rojas T; Jacobs S; Zapotocky M; Sumerauer D; Perek-Polnik M; Dufour C; van Vuurden D; Slavc I; Gojo J; Pickles JC; Gerber NU; Massimino M; Gil-da-Costa MJ; Garami M; Kumirova E; Sehested A; Scheie D; Cruz O; Moreno L; Cho J; Zeller B; Bovenschen N; Grotzer M; Alderete D; Snuderl M; Zheludkova O; Golanov A; Okonechnikov K; Mynarek M; Juhnke BO; Rutkowski S; Schüller U; Pizer B; von Zezschwitz B; Kwiecien R; Wechsung M; Konietschke F; Hwang EI; Sturm D; Pfister SM; von Deimling A; Rushing EJ; Ryzhova M; Hauser P; Łastowska M; Wesseling P; Giangaspero F; Hawkins C; Figarella-Branger D; Eberhart C; Burger P; Gessi M; Korshunov A; Jacques TS; Capper D; Pietsch T; Kool M
    Neuro Oncol; 2021 Sep; 23(9):1597-1611. PubMed ID: 34077956
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular targeting therapies for neuroblastoma: Progress and challenges.
    Zafar A; Wang W; Liu G; Wang X; Xian W; McKeon F; Foster J; Zhou J; Zhang R
    Med Res Rev; 2021 Mar; 41(2):961-1021. PubMed ID: 33155698
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Neuroblastoma patient-derived cultures are enriched for a mesenchymal gene signature and reflect individual drug response.
    Hee E; Wong MK; Tan SH; Choo Z; Kuick CH; Ling S; Yong MH; Jain S; Lian DWQ; Ng EHQ; Yong YFL; Ren MH; Syed Sulaiman N; Low SYY; Chua YW; Syed MF; Lim TKH; Soh SY; Iyer P; Seng MSF; Lam JCM; Tan EEK; Chan MY; Tan AM; Chen Y; Chen Z; Chang KTE; Loh AHP
    Cancer Sci; 2020 Oct; 111(10):3780-3792. PubMed ID: 32777141
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Level of Seven Neuroblastoma-Associated mRNAs Detected by Droplet Digital PCR Is Associated with tumor Relapse/Regrowth of High-Risk Neuroblastoma Patients.
    Thwin KKM; Ishida T; Uemura S; Yamamoto N; Lin KS; Tamura A; Kozaki A; Saito A; Kishimoto K; Mori T; Hasegawa D; Kosaka Y; Nino N; Takafuji S; Iijima K; Nishimura N
    J Mol Diagn; 2020 Feb; 22(2):236-246. PubMed ID: 31837427
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Adult-onset neuroblastoma: Report of seven cases with molecular genetic characterization.
    Duan K; Dickson BC; Marrano P; Thorner PS; Chung CT
    Genes Chromosomes Cancer; 2020 Apr; 59(4):240-248. PubMed ID: 31749253
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Neuroblastoma in a Neonate: A Case Report.
    Jnah AJ; Evans SK; Sewell K; Trembath A
    Neonatal Netw; 2019 Nov; 38(6):341-347. PubMed ID: 31712398
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Murine neuroblastoma cell lines developed by conditional reprogramming preserve heterogeneous phenotypes observed in vivo.
    Krawczyk E; Hong SH; Galli S; Trinh E; Wietlisbach L; Misiukiewicz SF; Tilan JU; Chen YS; Schlegel R; Kitlinska J
    Lab Invest; 2020 Jan; 100(1):38-51. PubMed ID: 31409888
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The role of β-catenin and paired-like homeobox 2B (phox2b) expression in neuroblastoma patients; predictive and prognostic value.
    El-Shazly SS; Hassan NM; Abdellateif MS; El Taweel MA; Abd-Elwahab N; Ebeid EN
    Exp Mol Pathol; 2019 Oct; 110():104272. PubMed ID: 31220430
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Extra-Adrenal Adult Neuroblastoma With Aberrant germ cell Marker Expression: Maturation After Chemotherapy as an Important Clue to a Challenging Diagnosis.
    Martinez-Ciarpaglini C; Machado I; Yoshida A; Nieto G; Berbegall AP; Blanquer-Maceíras MT; Noguera R; Ferrández A; Navarro S
    Int J Surg Pathol; 2019 Aug; 27(5):568-573. PubMed ID: 30907195
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pleiotropic effect of common
    Zhao J; Zhu Y; Xie X; Yao Y; Zhang J; Zhang R; Huang L; Cheng J; Xia H; He J; Zhang Y
    Aging (Albany NY); 2019 Feb; 11(4):1252-1261. PubMed ID: 30799307
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma.
    Popov A; Druy A; Shorikov E; Verzhbitskaya T; Solodovnikov A; Saveliev L; Tytgat GAM; Tsaur G; Fechina L
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):535-542. PubMed ID: 30603901
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries.
    Boeva V; Louis-Brennetot C; Peltier A; Durand S; Pierre-Eugène C; Raynal V; Etchevers HC; Thomas S; Lermine A; Daudigeos-Dubus E; Geoerger B; Orth MF; Grünewald TGP; Diaz E; Ducos B; Surdez D; Carcaboso AM; Medvedeva I; Deller T; Combaret V; Lapouble E; Pierron G; Grossetête-Lalami S; Baulande S; Schleiermacher G; Barillot E; Rohrer H; Delattre O; Janoueix-Lerosey I
    Nat Genet; 2017 Sep; 49(9):1408-1413. PubMed ID: 28740262
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Inhibition of WNT signaling reduces differentiation and induces sensitivity to doxorubicin in human malignant neuroblastoma SH-SY5Y cells.
    Suebsoonthron J; Jaroonwitchawan T; Yamabhai M; Noisa P
    Anticancer Drugs; 2017 Jun; 28(5):469-479. PubMed ID: 28240680
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Highly sensitive assessment of neuroblastoma minimal residual disease in ovarian tissue using RT-qPCR-A strategy for improving the safety of fertility restoration.
    Grèze V; Brugnon F; Chambon F; Halle P; Canis M; Amiot C; Grémeau AS; Pereira B; Yáñez Peralta Y; Tchirkov A; Kanold J
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27734578
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.